Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Efficacy and Safety of VYD222 for Prevention of COVID-19 (CANOPY)

NCT06039449 is registered in ClinicalTrials.gov with Invivyd, Inc. as lead sponsor.

NCT NCT06039449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06039449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Efficacy and Safety of VYD222 for Prevention of COVID-19 (CANOPY)
Lead sponsor
Invivyd, Inc.
Phase
Phase 3
Overall status
Completed
Start date
September 8, 2023
Completion date
November 19, 2024
Enrollment
790 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, sars-cov-2